key: cord-0840705-ow0eyguc authors: Puius, Yoram A.; Bartash, Rachel M.; Zingman, Barry S. title: Maintaining mask momentum in transplant recipients date: 2021-08-11 journal: Transpl Infect Dis DOI: 10.1111/tid.13697 sha: 830710911e72d10c0359bdf17de28e58b2965a6a doc_id: 840705 cord_uid: ow0eyguc The widespread use of facemasks has been a crucial element in the control of the SARS‐CoV‐2 pandemic. With mounting evidence for mask efficacy against respiratory infectious diseases and greater acceptability of this intervention, it is proposed that masking should continue after the pandemic has abated to protect some of our most vulnerable patients, recipients of stem cell and solid organ transplants. This may involve not only masking these high‐risk patients, but possibly their close contacts and the healthcare workers involved in their care. We review the evidence for mask efficacy in prevention of respiratory viruses other than SARS‐CoV‐2 and address the burden of disease in transplant recipients. Although we acknowledge that there are limited data on masking to prevent infection in transplant recipients, we propose a framework for the study and implementation of routine masking as a part of infection prevention interventions after transplantation. The widespread use of facemasks has been a crucial element in the control of the SARS-CoV-2 pandemic. With mounting evidence for mask efficacy against respiratory infectious diseases and greater acceptability of this intervention, it is proposed that masking should continue after the pandemic has abated to protect some of our most vulnerable patients, recipients of stem cell and solid organ transplants. This may involve not only masking these high-risk patients, but possibly their close contacts and the healthcare workers involved in their care. We review the evidence for mask efficacy in prevention of respiratory viruses other than SARS-CoV-2 and address the burden of disease in transplant recipients. Although we acknowledge that there are limited data on masking to prevent infection in transplant recipients, we propose a framework for the study and implementation of routine masking as a part of infection prevention interventions after transplantation. bone marrow transplant, COVID-19, masks, respiratory virus, SARS-CoV-2, solid organ transplant, stem cell transplant The use of facemasks is a simple and inexpensive intervention that decreases spread of severe acute respiratory syndrome coro- The preponderance of evidence before the SARS-CoV-2 pandemic suggests that masks decrease spread of RVIs, including a recent metaanalysis of 21 studies which estimated that mask use by HCWs may reduce transmission by 80%, and mask use in the community may reduce transmission by 47%. 10 However, other meta-analyses have noted that data quality is limited by potential bias, variable outcomes, and poor compliance with studied interventions. 11 Community mitigation measures during the COVID-19 pandemic have generally included masking, which has essentially created largescale experiments on the efficacy of this intervention in preventing droplet-borne infections. Institution of these measures has been shown to be effective in many countries and for many organisms (Table 1) . Although the impact of masking alone cannot be determined from these results, it has been a consistent component in all interventions which have had a major impact on RVI transmission. HSCT and SOT patients are at high risk for RVIs, particularly during the first 6 months after transplantation. In the immunocompetent population, RVIs are typically self-limited, although not without mor-bidity (e.g., RSV in neonates and infants) or mortality (e.g., influenza). Treatment is generally supportive, with the exception of neuraminidase inhibitors for influenza. However, RVIs result in greater morbidity and mortality in the immunocompromised host (Table 2 ). Due to this significant burden of disease, a number of treatment modalities have been explored in HSCT or SOT recipients but are often not recommended due to low efficacy, toxicity, or cost. For example, cidofovir may be given for treatment of adenovirus but supportive data are lacking. 12, 13 Ribavirin and intravenous immunoglobulin have unclear benefit in treating other respiratory viruses, and palivizumab has demonstrated benefit only as prophylaxis against RSV in high-risk neonates. 4, 5, 14 Another approach to the burden of RVIs in HSCT and SOT recipients is vaccination. Studies have shown that HSCT and SOT recipients typically respond poorly to vaccination 15, 16 and often shed RVIs for prolonged periods if infected. These make masking of the uninfected transplant patient attractive to prevent acquisition in the setting of impaired immunity, and also favor masking of the infected transplant recipient to control community transmission and nosocomial spread. The 2009 guideline for safe living after HSCT 17 recommends that others with upper respiratory infections (URIs) who are in close contact TA B L E 2 Seasonality, clinical syndromes, incidence, and mortality of selected respiratory viral infections. Ranges from the sources cites are approximate and/or inferred 19, 20 In addition to RVI prevention, the 2009 guidelines also suggest without evidence that HSCT recipients wear masks to prevent fungal infections during contact with soil, plants, or construction, 17 or in the hospital during periods of construction. 18 However, to our knowledge, there is only one small randomized trial regarding the use of FFP2 masks (similar to N95) in allogeneic HSCT recipients to prevent aspergillosis, 21 which showed no benefit. Similar to the HSCT guideline, a 2019 SOT guideline suggests that during contact with individuals with URIs, "both the infected person and the transplant recipient should wear a standard surgical mask. 22 " Masking of SOT recipients was also suggested during exposure to fungal spores or animal waste. 22 However, outside of these situations, routine masking was not recommended. It has been hypothesized that mask wearing may result in significant health and safety issues, such as hypoxemia, hypercapnia, acidemia, "self-contamination," tachycardia, and mood disorders, 25 although supporting data are scant. On the contrary, a meta-analysis suggests that the adverse effects of masking, including skin irritation, discomfort, inconvenience, and cost, are generally minor. 26 The COVID-19 pandemic has led to increased mask acceptance and has resulted in substantial self-reported 27 and observed 28 uptake. As COVID-19 will likely persist for years, mask-wearing is likely to gain further acceptance moving forward and may prove to be even more efficacious in transplant patients than previously demonstrated. It should be noted that most studies have primarily tested the use of a single surgical mask, which may have limited the ability to demonstrate efficacy. Emerging data suggest that other interventions (double surgical masks, N95, KN95, or even surgical plus cloth masks 29 ) may have higher efficacy. If tolerated and available, more protective masks would be preferable in the highest-risk periods after transplantation. Data from before the SARS-CoV-2 pandemic regarding efficacy of masking HSCT and SOT recipients are limited, and compliance with the intervention was low. As such, guidelines and care protocols often did not recommend routine masking. However, emerging data from the COVID-19 pandemic have provided strong evidence that routine masking protects against the spread of RVIs, which cause significant morbidity and mortality among HSCT and SOT recipients. In addition, the acceptability of masking has greatly increased during the pandemic and likely will remain high for years to come. Given the relatively lowcost, low-risk nature of masking and its many potential benefits, we propose the following: 1. Universal surgical masking (or more protective mask types) should be incorporated into HSCT and SOT protocols for at least 6 months after transplantation and after intensified immunosuppression. This should apply outside of the home, when in close contact with others, and during hospitalizations. Effectiveness of mask wearing to control community spread of SARS-CoV-2 Werler MM. Mask adherence and rate of COVID-19 across the United States An evidence review of face masks against COVID-19 Respiratory virus infections of the stem cell transplant recipient and the hematologic malignancy patient American Society of Transplantation Infectious Diseases Community of P. RNA respiratory viral infections in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings 19-and-medical-devices/face-masksincluding-surgical-masks-and-respirators-covid-19 Importance of nonpharmaceutical interventions in lowering the viral inoculum to reduce susceptibility to infection by SARS-CoV-2 and potentially disease severity. The Lancet Infectious Diseases Expiratory aerosol particle escape from surgical masks due to imperfect sealing Efficacy of face mask in preventing respiratory virus transmission: a systematic review and meta-analysis Physical interventions to interrupt or reduce the spread of respiratory viruses Adenovirus in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 Respiratory viruses in transplant recipients: more than just a cold. Clinical syndromes and infection prevention principles Serologic vaccination response after solid organ transplantation: a systematic review Measuring immune response to commonly used vaccinations in adult recipients of allogeneic hematopoietic cell transplantation Safe living after hematopoietic cell transplantation Infection prevention and control in health-care facilities in which hematopoietic cell transplant recipients are treated Universal mask usage for reduction of respiratory viral infections after stem cell transplant: a prospective trial Masks for prevention of respiratory viruses on the BMT unit: results of a quality initiative A prospective, randomised study on the use of well-fitting masks for prevention of invasive aspergillosis in high-risk patients Strategies for safe living following solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice A survey of infection prevention and control practices among solid organ transplantation centers Strategies for safe living among lung transplant recipients: a single-center survey Facemasks in the COVID-19 era: a health hypothesis Downsides of face masks and possible mitigation strategies: a systematic review and meta-analysis Mask-wearing and control of SARS-CoV-2 transmission in the USA: a cross-sectional study Observed face mask use at six universities -United States Fitted filtration efficiency of double masking during the COVID-19 pandemic Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand Evaluation of seasonal respiratory virus activity before and after the statewide COVID-19 shelter-in-place order in northern california The impact of the coronavirus disease 2019 epidemic on notifiable infectious diseases in Taiwan: a database analysis Decreased influenza activity during the COVID-19 pandemic -United States Very little influenza in the WHO European Region during the 2020/21 season Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data Respiratory viral infections in solid organ and hematopoietic stem cell transplantation Maintaining mask momentum in transplant recipients The authors declare no conflict of interest All authors contributed to the drafting, review, and final approval of this manuscript.